Gurunadh Reddy Chichili gurunadh.guru@astellas.com & | Highly motivated, innovative, and performance driven professional with 15+ years of industry experience and proven expertise in advancing the biologics from discovery to clinical testing KEY ACCOMPLISHMENTS • Delivered the Pipeline: Led multiple projects from discovery through proof of concept, candidate selection and advanced two bispecific DART candidate drugs from research into IND • Added Value: Coordinated cross-functional product development team and filed IND for CD123xCD3 DART program, IND enabling activities for two immune modulators • Translational Medicine: Established core functional translational group to support 3 phase 1 studies in solid and liquid tumor indications • Business Development: Delivered data packages supporting due diligence for successful out-licensing partnerships with major pharma companies KEY STRENGTHS • Established and streamlined core immune-oncology functional research capabilities for lead selection and optimization, comprehensive knowledge of antibody-based drug development with the focus on T cell directed cancer immunotherapy, provided leadership to sub-teams in multidisciplinary matrix environment • Managed external partnerships, established collaborative relationships with KOLs, evaluated and worked with CROs, serve as the primary point of contact between the translational medicine and with clinical development teams • investigated the mechanism of action of drugs to generate insights to leverage drug discovery, characterize disease (sub)populations, and predict treatment response (personalized medicine) • Participated in authoring IND documents and the development and writing of Phase 1 and 2 studyndesign, strong knowledge of cancer biology, immunology, biomarkers, and early-stage drug development Specialties: Monoclonal antibody based therapeutics, discovery, lead optimization, preclinical development, translational medicine Bispecific antibodies, solid and liquid tumors, Immune cell signaling

Gurunadh Reddy Chichili

Highly motivated, innovative, and performance driven professional with 15+ years of industry experience and proven expertise in advancing...

Chicago, Chicago, United States

*50 free lookup(s) per month.

No credit card required.

Gurunadh Reddy Chichili’s Emails [email protected]

Gurunadh Reddy Chichili’s Phone Numbers No phone number available.

Social Media

Gurunadh Reddy Chichili’s Location Chicago, Chicago, United States

Gurunadh Reddy Chichili’s Expertise Highly motivated, innovative, and performance driven professional with 15+ years of industry experience and proven expertise in advancing the biologics from discovery to clinical testing KEY ACCOMPLISHMENTS • Delivered the Pipeline: Led multiple projects from discovery through proof of concept, candidate selection and advanced two bispecific DART candidate drugs from research into IND • Added Value: Coordinated cross-functional product development team and filed IND for CD123xCD3 DART program, IND enabling activities for two immune modulators • Translational Medicine: Established core functional translational group to support 3 phase 1 studies in solid and liquid tumor indications • Business Development: Delivered data packages supporting due diligence for successful out-licensing partnerships with major pharma companies KEY STRENGTHS • Established and streamlined core immune-oncology functional research capabilities for lead selection and optimization, comprehensive knowledge of antibody-based drug development with the focus on T cell directed cancer immunotherapy, provided leadership to sub-teams in multidisciplinary matrix environment • Managed external partnerships, established collaborative relationships with KOLs, evaluated and worked with CROs, serve as the primary point of contact between the translational medicine and with clinical development teams • investigated the mechanism of action of drugs to generate insights to leverage drug discovery, characterize disease (sub)populations, and predict treatment response (personalized medicine) • Participated in authoring IND documents and the development and writing of Phase 1 and 2 studyndesign, strong knowledge of cancer biology, immunology, biomarkers, and early-stage drug development Specialties: Monoclonal antibody based therapeutics, discovery, lead optimization, preclinical development, translational medicine Bispecific antibodies, solid and liquid tumors, Immune cell signaling

Gurunadh Reddy Chichili’s Current Industry Astellas Pharma

Not the Gurunadh Reddy Chichili you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Astellas Pharma

Senior Director, Immunology Biomarkers, Clinical Pharmacology Fellow

Thu Apr 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Astellas Pharma

Director, Immunology Biomarkers, Global Clinical Pharmacology and Exploratory Development

Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Macrogenics

Senior Scietist

Wed Jan 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Macrogenics

Scientist II

Sun Apr 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Dec 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Nitto Denko

Senior Scientist, Team Lead - High-throughput Screening, Preclinical assay development

Mon Nov 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Mar 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Oklahoma Medical Research Foundation

Senior Research Scientist

Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jan 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Oklahoma Medical Research Foundation

Associate Research Scientist

Sun May 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)

University Of Hohenheim

PhD student

Wed Aug 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Apr 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)

Lv Prasad Eye Institute Hyderabad

Scientifi Assistant

Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Sep 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)

Mahyco

Research assistant

Mon Mar 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time)

Skills

Languages

FAQ About Gurunadh Reddy Chichili

Gurunadh Reddy Chichili is located at
Chicago, Chicago, United States

Gurunadh Reddy Chichili is a
Highly motivated, innovative, and performance driven professional with 15+ years of industry experience and proven expertise in advancing the biologics from discovery to clinical testing KEY ACCOMPLISHMENTS • Delivered the Pipeline: Led multiple projects from discovery through proof of concept, candidate selection and advanced two bispecific DART candidate drugs from research into IND • Added Value: Coordinated cross-functional product development team and filed IND for CD123xCD3 DART program, IND enabling activities for two immune modulators • Translational Medicine: Established core functional translational group to support 3 phase 1 studies in solid and liquid tumor indications • Business Development: Delivered data packages supporting due diligence for successful out-licensing partnerships with major pharma companies KEY STRENGTHS • Established and streamlined core immune-oncology functional research capabilities for lead selection and optimization, comprehensive knowledge of antibody-based drug development with the focus on T cell directed cancer immunotherapy, provided leadership to sub-teams in multidisciplinary matrix environment • Managed external partnerships, established collaborative relationships with KOLs, evaluated and worked with CROs, serve as the primary point of contact between the translational medicine and with clinical development teams • investigated the mechanism of action of drugs to generate insights to leverage drug discovery, characterize disease (sub)populations, and predict treatment response (personalized medicine) • Participated in authoring IND documents and the development and writing of Phase 1 and 2 studyndesign, strong knowledge of cancer biology, immunology, biomarkers, and early-stage drug development Specialties: Monoclonal antibody based therapeutics, discovery, lead optimization, preclinical development, translational medicine Bispecific antibodies, solid and liquid tumors, Immune cell signaling Astellas Pharma

Gurunadh Reddy Chichili currently works in the
Astellas Pharma

Gurunadh Reddy Chichili specializes in
Highly motivated, innovative, and performance driven professional with 15+ years of industry experience and proven expertise in advancing the biologics from discovery to clinical testing KEY ACCOMPLISHMENTS • Delivered the Pipeline: Led multiple projects from discovery through proof of concept, candidate selection and advanced two bispecific DART candidate drugs from research into IND • Added Value: Coordinated cross-functional product development team and filed IND for CD123xCD3 DART program, IND enabling activities for two immune modulators • Translational Medicine: Established core functional translational group to support 3 phase 1 studies in solid and liquid tumor indications • Business Development: Delivered data packages supporting due diligence for successful out-licensing partnerships with major pharma companies KEY STRENGTHS • Established and streamlined core immune-oncology functional research capabilities for lead selection and optimization, comprehensive knowledge of antibody-based drug development with the focus on T cell directed cancer immunotherapy, provided leadership to sub-teams in multidisciplinary matrix environment • Managed external partnerships, established collaborative relationships with KOLs, evaluated and worked with CROs, serve as the primary point of contact between the translational medicine and with clinical development teams • investigated the mechanism of action of drugs to generate insights to leverage drug discovery, characterize disease (sub)populations, and predict treatment response (personalized medicine) • Participated in authoring IND documents and the development and writing of Phase 1 and 2 studyndesign, strong knowledge of cancer biology, immunology, biomarkers, and early-stage drug development Specialties: Monoclonal antibody based therapeutics, discovery, lead optimization, preclinical development, translational medicine Bispecific antibodies, solid and liquid tumors, Immune cell signaling

Gurunadh Reddy Chichili speaks the following languages:
No languages available.

Gurunadh Reddy Chichili has prior experience in the following industries:
Astellas Pharma , Macrogenics , Macrogenics , Nitto Denko , Oklahoma Medical Research Foundation , Oklahoma Medical Research Foundation , University Of Hohenheim , Lv Prasad Eye Institute Hyderabad , Mahyco

Gurunadh Reddy Chichili has the following professional experience:
Astellas Pharma , Astellas Pharma , Macrogenics , Macrogenics , Nitto Denko , Oklahoma Medical Research Foundation , Oklahoma Medical Research Foundation , University Of Hohenheim , Lv Prasad Eye Institute Hyderabad , Mahyco .